Profil
Stephen S.
Yoder is currently Co-Managing Director at Pieris Pharmaceuticals GmbH.
Former positions include President & Chief Executive Officer at Marika, Inc., President, Chief Executive Officer & Director at Pieris AG, President, Chief Executive Officer & Director at Pieris Pharmaceuticals, Inc. from 2014 to 2024, Chief Executive Officer at Palvella Therapeutics, Inc., and General Counsel at MorphoSys AG from 1999 to 2010.
Education includes undergraduate studies at Grove City College and graduate studies at George Washington University Law School.
Aktive Positionen von Stephen Yoder
| Unternehmen | Position | Beginn |
|---|---|---|
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Operates as a biotechnology company | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Stephen Yoder
| Unternehmen | Position | Ende |
|---|---|---|
| PIERIS PHARMACEUTICALS | Vorstandsvorsitzender | 13.12.2024 |
| MORPHOSYS AG | General Counsel | - |
Marika, Inc.
Marika, Inc. Personnel ServicesCommercial Services Provides online job marketplace services | Vorstandsvorsitzender | - |
Pieris AG
Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Vorstandsvorsitzender | - |
Ausbildung von Stephen Yoder
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Marika, Inc.
Marika, Inc. Personnel ServicesCommercial Services Provides online job marketplace services | Commercial Services |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Grove City College
Grove City College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris AG
Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Health Technology |
George Washington University Law School
George Washington University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
















